10x Genomics to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 07 2020 - 4:05PM
10x Genomics, Inc. (Nasdaq: TXG), today announced the company will
be participating in the upcoming 38th Annual J.P. Morgan Healthcare
Conference in San Francisco, CA.
10x Genomics’ management is scheduled to present on Tuesday,
January 14 at 8:30 a.m. Pacific Time. Interested parties may access
a live and archived webcast of the presentation on the “Investors”
section of the company’s website at:
https://investors.10xgenomics.com/.
About 10x Genomics10x Genomics is a life
science technology company building products to interrogate,
understand and master biology to advance human health. The
company’s integrated solutions include instruments, consumables and
software for analyzing biological systems at a resolution and scale
that matches the complexity of biology. 10x Genomics products have
been adopted by researchers around the world including 93 of the
top 100 global research institutions and 90 percent of the top 20
global pharmaceutical companies, and have been cited in over 570
research papers on discoveries ranging from oncology to immunology
and neuroscience. The company's patent portfolio comprises more
than 650 issued patents and patent applications.
Disclosure Information10x Genomics uses filings
with the Securities and Exchange Commission, its website
(www.10xgenomics.com), press releases, public conference calls,
public webcasts and its social media accounts as means of
disclosing material non-public information and for complying with
its disclosure obligations under Regulation FD.
ContactsInvestors:investors@10xgenomics.com
Media:media@10xgenomics.com
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Jun 2024 to Jul 2024
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Jul 2023 to Jul 2024